甘化科工(000576) - 2020 Q1 - 季度财报

Revenue and Profitability - Revenue for Q1 2020 was CNY 124,740,384.74, an increase of 25.44% compared to CNY 99,443,576.16 in the same period last year[6] - Net profit attributable to shareholders decreased by 64.79% to CNY 8,648,822.68 from CNY 24,563,232.04 year-on-year[6] - Net profit excluding non-recurring gains and losses increased by 77.11% to CNY 22,757,930.85 compared to CNY 12,849,699.16 in the previous year[6] - Basic and diluted earnings per share decreased by 64.86% to CNY 0.0195 from CNY 0.0555 year-on-year[6] - Net profit for Q1 2020 was CNY 11,590,052.55, a decrease of 56.1% from CNY 26,409,725.10 in Q1 2019[46] - The net profit attributable to the parent company was CNY 8,648,822.68, down 64.8% from CNY 24,563,232.04 in the previous year[46] - Basic earnings per share for Q1 2020 were CNY 0.0195, compared to CNY 0.0555 in Q1 2019, representing a decline of 64.9%[46] Cash Flow and Operating Activities - Net cash flow from operating activities improved by 132.07%, reaching CNY 29,390,865.65, compared to a negative CNY 91,645,463.79 in the same period last year[6] - Operating cash inflow for the current period reached CNY 118,854,765.09, a significant increase from CNY 75,348,822.66 in the previous period, reflecting a growth of approximately 57.5%[52] - Total cash outflow from operating activities decreased to CNY 89,463,899.44 from CNY 166,994,286.45, a reduction of about 46.5%[53] - Cash received from sales of goods and services increased by RMB 53.4462 million, a growth of 82.7%, primarily due to increased cash receipts from sugar sales[18] - The company reported a significant increase in cash received from sales, amounting to CNY 118,075,524.52, compared to CNY 64,629,306.31 in the previous period, representing an increase of approximately 82.5%[52] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,586,190,934.92, a slight increase of 0.04% from CNY 1,585,635,909.95 at the end of the previous year[6] - Total liabilities decreased to CNY 428,303,989.83 from CNY 439,777,085.60, reflecting a reduction of about 2.7%[38] - The company's equity attributable to shareholders increased to CNY 1,132,366,584.30 from CNY 1,123,411,113.89, a growth of approximately 0.8%[39] - Current assets totaled CNY 540,096,400.34, showing a marginal decrease from CNY 542,023,537.63 at the end of 2019[36] - Total liabilities reached CNY 439,777,085.60, with current liabilities at CNY 248,557,606.93[58] Investments and Financial Management - The company reported a total investment of 10,210,000 CNY in bank wealth management products, with an outstanding balance of 8,973,000 CNY[26] - The company’s financial management strategy includes investments in government bonds and corporate debt[28] - The company’s financial performance indicates a focus on maintaining liquidity and managing investment risks effectively[28] - The total securities investment at the end of the period was 68,076,000 CNY, with a loss of 19,866,000 CNY reported[24] - The company has not engaged in derivative investments during the reporting period[30] Changes in Fair Value and Other Financial Metrics - The company reported a loss of CNY 19,190,063.58 from changes in the fair value of trading financial assets, primarily due to secondary market stock fluctuations[9] - The fair value change income decreased by RMB 34.5677 million, a decline of 215.37%, mainly due to floating losses in the company's securities investments[17] - The company experienced a significant loss in fair value changes amounting to CNY -18,517,269.19 compared to a gain of CNY 16,050,434.22 in the previous year[45] Shareholder Information and Corporate Governance - The total number of ordinary shareholders at the end of the reporting period was 27,764[12] - The company did not conduct any repurchase transactions during the reporting period[14] - The company did not have any overdue commitments from actual controllers, shareholders, or related parties during the reporting period[20] - There were no violations regarding external guarantees during the reporting period[32] - The company has not undergone an audit for the first quarter report[63] Research and Development - Research and development expenses for Q1 2020 were CNY 4,071,917.37, a decrease from CNY 4,629,621.04 in the same period last year[45]